Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®
Herbal medicines are used worldwide and with an increasing popularity in Western countries. Although often perceived as ‘naturally safe’, herbals may cause severe adverse drug reactions (ADRs), with immediate allergic reactions being particularly life threatening.
The aim of this study was to analyse immediate allergy-like ADRs to herbals documented in VigiBase®, the WHO international pharmacovigilance database.
The documentation of all suspected ADRs in association with herbal exposure reported to VigiBase® from 1969 to August 2014 was retrieved. Among all reports in which WHO-ART reaction terms were indicative of acute allergic reactions, those classified as ‘suspect’ with a documented causality assessment and latency time of ≤1 day were selected. For the most frequent specific herbal–ADR combinations, the information component (IC) as a measure of disproportionality based on Bayesian statistics was calculated.
We identified 757 reports out of 1039 ADRs. Products with mixed herbals (36.0 %) as well as those administered orally (63.2 %) were predominant. The most frequent reactions were urticaria and rash (49.2 %). Anaphylactic reactions accounted for 9.5 %. Disproportionally frequent reporting of mouth edema (IC = 1.81) and anaphylactic reactions (IC = 1.24) to Phleum pretense were noted.
Our findings indicate that herbal medicines for oral use carry a risk of causing immediate allergy-like ADRs. Studies using the Vigibase® database can identify specific combinations of particular herbs and adverse reactions. Healthcare professionals and patients should be aware of these risks and report any serious adverse experiences.
- 3.Wu CH, Wang CC, Tsai MT, Huang WT, Kennedy J. Trend and pattern of herb and supplement use in the United States: results from the 2002, 2007, and 2012 national health interview surveys. Evid Based Complement Altern Med eCAM. 2014;2014:872320.Google Scholar
- 6.Wiesener S, Falkenberg T, Hegyi G, Hok J, Roberti di Sarsina P, Fonnebo V. Legal status and regulation of complementary and alternative medicine in Europe. Forsch Komplement. 2012;19:29–36.Google Scholar
- 10.Ventola CL. Current issues regarding complementary and alternative medicine (CAM) in the United States: Part 1: the widespread use of CAM and the need for better-informed health care professionals to provide patient counseling. P & T Peer Rev J Formul Manag. 2010;35(8):461–8.Google Scholar
- 14.WHO Uppsala Monitoring Centre. [cited 2015]. http://www.who-umc.org. Accessed 20 Feb 2016.
- 15.WHO Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. [cited 2015]. http://www.who-umc.org/Graphics/26649.pdf. Accessed 20 Feb 2016.
- 16.WHO Uppsala Monitoring Centre. WHO-ART - MedDRA Cross Reference Tool. [cited 2015]. http://www.umc-products.com/DynPage.aspx?id=73560&mn1=1107&mn2=1664&mn3=6045. Accessed 20 Feb 2016.
- 18.WHO. WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems. [cited 2015]. http://apps.who.int/medicinedocs/en/d/Js7148e/. Accessed 20 Feb 2016.
- 19.Murphy K, Gawchik S, Bernstein D, Andersen J, Pedersen MR. A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma. J Negat Results Biomed. 2013;12:10.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Andrographis paniculata. In: Jellin JM, Gregory PJ, Calvillo A, et al. Natural medicines comprehensive database. Stockton, CA: Therapeutic Research Center. http://www.naturaldatabase.com/. Accessed 15 Oct 2015.
- 35.Alomar MJ. Factors affecting the development of adverse drug reactions (Review article). Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2014;22(2):83–94.Google Scholar
- 37.Food allergy: A practice parameter update—2014. [cited 2015]. http://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Food-Allergy-A-Practice-Parameter-Update-2014.pdf. Accessed 20 Feb 2016.
- 40.Simons FE, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Tanno LK, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015;8(1):32.Google Scholar
- 42.Rive CM, Bourke J, Phillips EJ. Testing for drug hypersensitivity syndromes. Clin Biochem Rev Aust Assoc Clin Biochem. 2013;34(1):15–38.Google Scholar